Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study

NCT: NCT03680781 · COMPLETED

NCT IDNCT03680781
StatusCOMPLETED
Start Date2018-04-13
Completion2024-12-02

Brief Summary

This study evaluates the effectiveness of re-treatment using accelerated schedule of intermittent theta-burst stimulation for treatment-resistant depression. This is an open label study.

Frequently Asked Questions

What is Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study?

Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study is a clinical trial registered under NCT03680781. Current status: COMPLETED.

What is the status of NCT03680781?

The current status of NCT03680781 (Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study) is: COMPLETED.

When did Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study start?

Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study started on 2018-04-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑